Quantcast
Last updated on April 16, 2014 at 5:31 EDT

Latest Boehringer Ingelheim Stories

2013-10-17 23:32:34

The law firms of Edward M. Bernstein & Associates, The Michael Brady Lynch Firm and Peiffer, Rosca, Abdullah & Carr announced the successful remand of a Las Vegas Pradaxa bleeding death case to Clark County, Nevada. Las Vegas, Nevada (PRWEB) October 17, 2013 Today the law firms of Edward M. Bernstein & Associates, The Michael Brady Lynch Firm and Peiffer, Rosca, Abdullah & Carr announced the successful remand of a Las Vegas Pradaxa bleeding death case to Clark County,...

2013-10-09 12:26:15

Conference brings together Daughters from across the United States to build awareness of devastating disease CULVER CITY, Calif., Oct. 9, 2013 /PRNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) is pleased to announce the first ever Daughters of Pulmonary Fibrosis Leadership Conference to be held at the Marriott Marquis in downtown Atlanta, Friday, October 11 to Saturday, October 12. This unique program will bring together relatives of past and present patients with idiopathic...

2013-10-08 08:28:26

Collaborative trial from Boehringer Ingelheim and Presidio Pharmaceuticals investigates triple-DAA regimen of faldaprevir, deleobuvir and PPI-668 RIDGEFIELD, Conn., Oct. 8, 2013 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that interim data from its Phase 2 hepatitis C (HCV) clinical collaboration (NCT01859962) with Presidio Pharmaceuticals have been accepted as a late breaker poster presentation at the 64th Annual Meeting of the American Association for the...

2013-10-03 08:29:13

INDIANAPOLIS, Oct. 3, 2013 /PRNewswire/ -- -- Company aims to overcome patent expirations through targeted growth initiatives, continued expense controls, and maturing Phase 3 pipeline -- Lilly expects to launch several new medicines beginning next year, returning the company to revenue growth and expanding margins after 2014 -- To date, positive Phase 3 results have led to a record seven regulatory submissions of four molecules in 2013 -- Lilly...

2013-10-02 23:24:34

Visible Health and BIPI collaborate to deliver updated drawMD Cardiology patient education iPad app. Austin, Texas (PRWEB) October 02, 2013 Visible Health announced today a collaboration with Boehringer Ingelheim Pharmaceuticals, Inc. to sponsor the popular drawMD Cardiology patient education app for the iPad. The drawMD app for the iPad allows doctors to create visual images that can be used to guide conversations about medical and surgical conditions and procedures with their patients....

2013-10-01 12:30:34

RIDGEFIELD, Conn., Oct. 1, 2013 /PRNewswire/ -- New data from Boehringer Ingelheim's hepatitis C virus (HCV) clinical development program have been accepted for presentation at the 64(th) Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), also known as The Liver Meeting(®), taking place November 1-5 in Washington, D.C. Presentations will include data from several studies evaluating Boehringer Ingelheim's investigational compound, faldaprevir,...

2013-09-27 23:02:25

Michael Patrick Doyle speaks on current updates of litigation against the Boehringer Ingelheim drug Pradaxa. Houston, TX (PRWEB) September 27, 2013 Doyle Raizner LLP partner Michael Patrick Doyle is speaking at American Association for Justice’ (AAJ) Pharmaceutical and Medical Device Ligation Update in Philadelphia. The CLE opportunity is exclusively for plaintiff trial lawyers. Doyle is presenting updates on the current state of litigation against the Boehringer Ingelheim drug...

2013-09-24 12:28:28

NEW YORK, Sept. 24, 2013 /PRNewswire/ -- In support of Pulmonary Fibrosis Awareness Month, Boehringer Ingelheim and the Coalition for Pulmonary Fibrosis (CPF) are teaming up to raise awareness of idiopathic pulmonary fibrosis, or IPF, a progressive and fatal disease that causes permanent scarring of the lungs, difficulty breathing, and prevents oxygen from getting to the body. This collaboration also features actress Rose McGowan, who is best known for her leading role in the hit...

2013-09-24 08:29:46

Two pooled analyses of data from clinical trials in adults with type 2 diabetes, including the elderly with normal renal function to severe renal impairment, found similar incidence of adverse events for linagliptin compared with placebo RIDGEFIELD, Conn. and INDIANAPOLIS, Sept. 24, 2013 /PRNewswire/ -- Boehringer Ingelheim and Eli Lilly and Company (Lilly; NYSE: LLY) today announced results from two post-hoc, pooled analyses of data from placebo-controlled clinical trials, which examined the...

2013-09-23 12:24:30

Pharmaceutical Leader to Bring More Health Education to More People with Exclusive Sponsorship of "Ritmo Dieta" Segment on "Sabado Gigante" Underscoring Diabetes Awareness and Healthy Living NEW YORK, Sept. 23, 2013 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI), one of the world's top 20 leading pharmaceutical companies today announced its collaboration with Univision Communications Inc. to launch its first integrated campaign for U.S. Hispanics. Leveraging...